A Long-Term, Multi-Center Clinical Study of Recombinant Human Factor VIII BAY W 6240) in Treatment of Hemophilia A.
Journal of the Japan Society of Blood Transfusion
doi 10.3925/jjtc1958.37.593
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1991
Authors
Publisher
Japan Society of Transfusion Medicine and Cell Therapy